AU7683196A - Peptide conjugates, use thereof as a drug, and compositions containing same - Google Patents

Peptide conjugates, use thereof as a drug, and compositions containing same

Info

Publication number
AU7683196A
AU7683196A AU76831/96A AU7683196A AU7683196A AU 7683196 A AU7683196 A AU 7683196A AU 76831/96 A AU76831/96 A AU 76831/96A AU 7683196 A AU7683196 A AU 7683196A AU 7683196 A AU7683196 A AU 7683196A
Authority
AU
Australia
Prior art keywords
lys
lysine
drug
compositions containing
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76831/96A
Inventor
Lucien Dussourd D'hinterland
Anne-Marie Pinel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Europeen de Biologie Cellulaire
Original Assignee
RECH DE PATHOLOGIE APPLIQUEE S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH DE PATHOLOGIE APPLIQUEE S filed Critical RECH DE PATHOLOGIE APPLIQUEE S
Publication of AU7683196A publication Critical patent/AU7683196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Peptide conjugates including a sequence of at least three amino acids selected from Lys-Lys-Gly, Gly-His-Lys and Glu-His-Lys, wherein "Lys" is Lysine or a halogenated derivative thereof, or a methylated Lysine derivative, particularly Methyl-Lysine and Dihydrobromo-Methyl-Lysine, said amino acids optionally being in D, L or DL form, and said sequence being chemically or physically conjugated with at least one compound selected from monocarboxylic acids of general formula (I): HOOC-R, or alcohol, aldehyde or amide derivatives thereof, and dicarboxylic acids of general formula (II): HOOC-R1-COOH, are disclosed. The use of such conjugates as a drug, and pharmaceutical or cosmetic compositions containing said conjugates, are also disclosed.
AU76831/96A 1995-11-15 1996-11-15 Peptide conjugates, use thereof as a drug, and compositions containing same Abandoned AU7683196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9513543A FR2741075B1 (en) 1995-11-15 1995-11-15 PEPTIDE CONJUGATES, THEIR USE AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM
FR9513543 1995-11-15
PCT/FR1996/001811 WO1997018235A1 (en) 1995-11-15 1996-11-15 Peptide conjugates, use thereof as a drug, and compositions containing same

Publications (1)

Publication Number Publication Date
AU7683196A true AU7683196A (en) 1997-06-05

Family

ID=9484595

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76831/96A Abandoned AU7683196A (en) 1995-11-15 1996-11-15 Peptide conjugates, use thereof as a drug, and compositions containing same

Country Status (9)

Country Link
EP (1) EP0869969B1 (en)
JP (1) JP2000512613A (en)
AT (1) ATE235508T1 (en)
AU (1) AU7683196A (en)
CA (1) CA2237993A1 (en)
DE (1) DE69627019T2 (en)
ES (1) ES2193272T3 (en)
FR (1) FR2741075B1 (en)
WO (1) WO1997018235A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7001992B2 (en) 1997-05-30 2006-02-21 Human Genome Sciences, Inc. Antibodies to secreted protein HEMCM42
EP1015477B1 (en) * 1997-05-30 2010-11-10 Human Genome Sciences, Inc. 32 Human secreted proteins
FR2802413B1 (en) * 1999-12-17 2003-10-31 Sederma Sa COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS CONTAINING THE N-PALMYTOYL-GLY-HYS-LYS TRIPEPTIDE FOR ELIMINATING, REDUCING OR PREVENTING THE APPEARANCE OF WRINKLES, WHEREVER THE LOCATION AND THE CAUSE
FR2810323B1 (en) * 2000-06-16 2002-09-06 Shiseido Int France COSMETIC USE OF A LIPOPEPTIDE
KR100753472B1 (en) * 2002-03-15 2007-08-31 주식회사 엘지생활건강 Fusion peptide comprising tat peptide and human type-? collagen derived peptide, its preparation method, and anti-aging cosmetic composition comprising the same
FR2857667B1 (en) 2003-07-18 2007-07-13 Inst Europ Biolog Cellulaire NEW PEPTIDE CONJUGATES USEFUL IN THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA
FR2857597B1 (en) 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair USE OF PEPTIDE CONJUGATES FOR THE PREPARATION OF COMPOSITIONS FOR THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA.
EP1737819B1 (en) 2004-03-26 2010-12-22 DSM IP Assets B.V. Amino acid and peptide conjugates of arylalkylic acids for cosmetic use
FR2870244B1 (en) * 2004-05-11 2011-01-07 Centre Nat Rech Scient ALPHA-MSH ANTAGONIST DIPEPTIDE CONJUGATES
FR2913603A1 (en) * 2007-03-15 2008-09-19 Michel Yvan Hocquaux COSMETIC COMPOSITION FOR SKIN CARE AGREED BY AESTHETIC TREATMENT SUCH AS SURGICAL INTERVENTION, LASER TREATMENT, DERMABRASION, PEELING CAT.INIST logo CNRS logo INIST Accueil / Home Imprimer / Print Contact / Contact PARTAGER / SHARE EXPORT Bookmark and Share Mendeley.
US20100310484A1 (en) * 2007-06-29 2010-12-09 Innovactiv Inc. Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
ES2605162T3 (en) * 2007-06-29 2017-03-13 Lucas Meyer Cosmetics Canada Inc. New compounds, use thereof in cosmetic and cosmo pharmaceutical applications, and compositions comprising them
PT2165698E (en) 2008-09-18 2016-06-23 Universkin Cosmetic composition designed to protect damaged skin
US7928067B2 (en) 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
DE102009055970B4 (en) * 2009-11-27 2014-04-17 Marcus Asam Cosmetic preparation of active ingredient
KR20140020840A (en) 2010-11-18 2014-02-19 이쉐믹스 엘엘씨 Lipoyl compounds and their use for treating ischemic injury
FR2986528B1 (en) * 2012-02-06 2015-12-04 Inst Europeen Biolog Cellulair NEW ANTI-AGING PEPTIDES
EP3615023B1 (en) 2017-04-25 2023-06-21 Ischemix LLC Lipoyl-glu-ala for the treatment of neurodegenerative damage caused by traumatic brain injury

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
DE4127790A1 (en) * 1991-08-22 1993-02-25 Wank Anna New oligopeptide(s) and metal complexes - used in skin-care cosmetics

Also Published As

Publication number Publication date
ES2193272T3 (en) 2003-11-01
CA2237993A1 (en) 1997-05-22
WO1997018235A1 (en) 1997-05-22
EP0869969A1 (en) 1998-10-14
FR2741075A1 (en) 1997-05-16
JP2000512613A (en) 2000-09-26
EP0869969B1 (en) 2003-03-26
DE69627019T2 (en) 2004-01-22
FR2741075B1 (en) 1998-01-30
DE69627019D1 (en) 2003-04-30
ATE235508T1 (en) 2003-04-15

Similar Documents

Publication Publication Date Title
AU7683196A (en) Peptide conjugates, use thereof as a drug, and compositions containing same
WO1996040757A3 (en) Lhrh antagonist peptides
AU7254491A (en) Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
EP0695759A3 (en) Human cancer inhibitory pentapeptide methyl esters
WO1999015549A3 (en) Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine
TR199802534T2 (en) Leptin (OB Protein) fragmanlar�
CA2012480A1 (en) Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
ATE308998T1 (en) LONG-ACTING MEDICATIONS AND MEDICINAL PRODUCTS CONTAINING SAME
FR2710340B1 (en) Alpha-MSH peptide derivatives and their application.
DK2016950T3 (en) Pharmaceutical composition comprising an exendin-4 peptide
AU7683296A (en) Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
WO1995013297A3 (en) Improved immunogenic compositions against human gastrin 17
EP0634999A4 (en) Novel amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels.
CA2111340A1 (en) Novel polypeptides and their use
EP0976402A3 (en) Vaccines for prevention of gram-negative bacterial infections and endotoxin-related diseases
AU2882792A (en) Tripeptide derivative anti-inflammatory agents
EP0644884A4 (en) Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels.
KR900016259A (en) Novel peptides and antidementants containing them
AU1377092A (en) Peptides for treatment
MX9803662A (en) Peptide derivatives of dolastatin 15 and their use.
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
EP0635000A4 (en) Novel phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels.
NO982227L (en) Urogenital carcinoma-TPL complex peptides and antibodies thereof
CA2247998A1 (en) Fragments of cr1 and their use